Alex Shlyankevich

Alex Shlyankevich has a diverse work experience in the healthcare and investment sectors. Alex has held roles such as Investment Director at Mansfield Bio-Incubator, Venture Partner at Asymmetry Ventures, and Business and Marketing Advisor at GiveVision. Alex has also served as President at Orot Yerushalaim and has been a Board Member for multiple companies including Constant Therapeutics, Felicitex Therapeutics Inc., NuPulseCV, Inc., and GiveVision. Additionally, they have been an Investor Member at Sky Ventures Group and a Senior Healthcare Analyst-Consultant at Forrester, where they led client engagements and provided consultation on various healthcare topics. Alex has extensive experience in sourcing investment candidates, conducting due diligences, and managing healthcare investment portfolios.

Alex Shlyankevich earned a Master's Degree in Pharmacy from the First Moscow State Medical University named after I.M. Sechenov in 1983. Alex went on to obtain a Doctor of Philosophy (Ph.D.) in Pharmaceutical Analysis from the same university between 1984 and 1988.